Ambrisentans farmakokinetik er ikke undersøgt hos patienter med svært nedsat leverfunktion (med eller uden cirrose).
The pharmacokinetics of ambrisentan in patients with severe hepatic impairment (with or without cirrhosis) has not been studied.